These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11509655)

  • 21. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth.
    Pierson-Mullany LK; Skildum A; Faivre E; Lange CA
    Breast Dis; 2003; 18():21-31. PubMed ID: 15687686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
    Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.
    Daniel AR; Lange CA
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14287-92. PubMed ID: 19706513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
    Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
    Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
    Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
    Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
    Wu J; Brandt S; Hyder SM
    Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
    Lee H; Jiang F; Wang Q; Nicosia SV; Yang J; Su B; Bai W
    Mol Endocrinol; 2000 Nov; 14(11):1882-96. PubMed ID: 11075819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
    Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
    Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
    Boldt S; Weidle UH; Kolch W
    Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor.
    Beck CA; Zhang Y; Weigel NL; Edwards DP
    J Biol Chem; 1996 Jan; 271(2):1209-17. PubMed ID: 8557652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
    Diep CH; Ahrendt H; Lange CA
    Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
    Hagan CR; Regan TM; Dressing GE; Lange CA
    Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of Stat3 activation by MEK kinase 1.
    Lim CP; Cao X
    J Biol Chem; 2001 Jun; 276(24):21004-11. PubMed ID: 11278353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer.
    Abreu-Martin MT; Chari A; Palladino AA; Craft NA; Sawyers CL
    Mol Cell Biol; 1999 Jul; 19(7):5143-54. PubMed ID: 10373563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.